The changes in cardiovascular prevention practice between 1995 and 2012 in the Czech Republic. A comparison of EUROASPIRE I, II, III and IV study

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064190%3A_____%2F14%3A%230000900" target="_blank" >RIV/00064190:_____/14:#0000900 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1016/j.crvasa.2014.01.008" target="_blank" >http://dx.doi.org/10.1016/j.crvasa.2014.01.008</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1016/j.crvasa.2014.01.008" target="_blank" >10.1016/j.crvasa.2014.01.008</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The changes in cardiovascular prevention practice between 1995 and 2012 in the Czech Republic. A comparison of EUROASPIRE I, II, III and IV study

Popis výsledku v původním jazyce

Definite evidence has been established such that coronary patients benefit from appropriate secondary prevention. A series of EUROASPIRE surveys evaluated the level of implementation of coronary heart disease (CHD) prevention Guidelines. We aimed to evaluate the changes in adherence to treatment targets during 16 years and to compare the mortality in Czech patients with manifest CHD. Four independent descriptive surveys were undertaken in 1995/96, 1999/2000, 2006/07 and 2012/13. Consecutive patients less than 71 years of age suffering for acute coronary event and/or revascularization procedure were identified and examined at least 6 months afterwards. The study population included 4 series of 331, 410, 421 and 372 patients. The prescription of basic pharmacotherapy markedly improved, namely use of statins increased more than 12 times (from 7.3% to 93.3%). Proportion of patients who underwent revascularization increased from 49% to 95%. Prevalence of hypercholesterolemia and raised bloo

Název v anglickém jazyce

The changes in cardiovascular prevention practice between 1995 and 2012 in the Czech Republic. A comparison of EUROASPIRE I, II, III and IV study

Popis výsledku anglicky

Definite evidence has been established such that coronary patients benefit from appropriate secondary prevention. A series of EUROASPIRE surveys evaluated the level of implementation of coronary heart disease (CHD) prevention Guidelines. We aimed to evaluate the changes in adherence to treatment targets during 16 years and to compare the mortality in Czech patients with manifest CHD. Four independent descriptive surveys were undertaken in 1995/96, 1999/2000, 2006/07 and 2012/13. Consecutive patients less than 71 years of age suffering for acute coronary event and/or revascularization procedure were identified and examined at least 6 months afterwards. The study population included 4 series of 331, 410, 421 and 372 patients. The prescription of basic pharmacotherapy markedly improved, namely use of statins increased more than 12 times (from 7.3% to 93.3%). Proportion of patients who underwent revascularization increased from 49% to 95%. Prevalence of hypercholesterolemia and raised bloo

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

<a href="/cs/project/NT13186" target="_blank" >NT13186: Sekundární prevence ICHS ve vybraném vzorku české populace - česká část studie EURASPIRE IV.</a><br>

Návaznosti

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Rok uplatnění

2014

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vase

ISSN

1803-7712

e-ISSN

—

Svazek periodika

56

Číslo periodika v rámci svazku

2

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

6

Strana od-do

"e91"-"e97"

Kód UT WoS článku

—

EID výsledku v databázi Scopus

—